Titan Prime, an inflatable penile prosthesis (IPP), will be available in the U.S. in late 2026. · GlobeNewswire Inc. The global leader within intimate healthcare today announced FDA approval of Titan ...

Prostate cancer is the most common malignancy among men, with over 160,000 new cases diagnosed annually in the United States. Although advances in surgery, radiotherapy, and hormone therapy have ...

The U.S. FDA’s recent approval of Boston Scientific Corp.’s Tenacio pump, a component for its AMS 700 inflatable penile prosthesis (IPP), is an “exciting milestone” for the company, Ronald Morton, ...

Diabetic men receiving an inflatable penile prosthesis have a 69% increased risk of device-associated infection compared with non-diabetics. The following article is part of conference coverage from ...

Implantable penile prostheses (IPPs) are an established treatment option for erectile dysfunction (ED), and are covered by insurance in about 80% of cases, reports a paper in the September issue of ...

Study flowchart of patient selection: Inclusion and exclusion criteria. ED, erectile dysfunction; EDITS, Erectile Dysfunction Inventory of Treatment Satisfaction; RCP, radical cystoprostatectomy; RP, ...

SAN ANTONIO — For men who develop both erectile dysfunction and climacturia and/or mild urinary incontinence after radical prostatectomy, an add-on maneuver to penile prosthesis insertion can address ...

The global leader within intimate healthcare today announced FDA approval of Titan Prime, an inflatable penile prosthesis (IPP) that represents the company’s next-generation device and will be ...

The global leader within intimate healthcare today announced FDA approval of Titan Prime, an inflatable penile prosthesis (IPP) that represents the company's next-generation device and will be ...